Shares of the Ozempic-maker fell while the rest of the market rose,as it's facing a hit to revenue from different directions.

European markets closed lower on Wednesday, with traders monitoring corporate earnings and awaiting the Federal Reserve’s ...

The share buy-back program is expected to be realized in the period from February 26, 2025, to August 15, 2025. The total ...

Novo Nordisk's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases.

Transactions made under the share buyback programme will be announced through Nasdaq Copenhagen on a weekly basis. The ...

As a licensed VASP under VARA’s globally recognized framework, DKK Digital is now authorized to offer a comprehensive suite ...

Financial report for the period 1 January 2025 to 31 March 2025 Operating profit increased by 22% in Danish kroner and by 20% ...

Nini Pryds, Henning Friis Poulsen, Irini Angelidaki, and Leif Oxenløwe each received a prestigious Villum Investigator grant, ...

In accordance with Section 31 of the Capital Market Act, it is hereby announced that ISS A/S as of today owns a total of 3,087,915 treasury shares of nominally DKK 1, hence less than 5% of the total ...

Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 ...

Welcome to the 2022 DKK EUR history summary. This is the Danish Krone (DKK) to Euro (EUR) exchange rate history data page for the year of 2022, covering 365 days of DKK EUR historical data.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.